课题基金 / 基金详情

Studies on the regulation of gene expression in lymphoid cells.

Studies on the regulation of gene expression in lymphoid cells.
淋巴细胞基因表达调控的研究。
批准号:
03044099
负责人:
KISHIMOTO Tadamitsu
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for international Scientific Research
财政年份:
1991
资助国家:
日本
项目状态:
已结题
起止时间:
1991 至 --

项目摘要

项目成果

KISHIMOTO Tadamitsu的其他基金

相似基金

相关文献

中文摘要
翻译
美日免疫学研讨会于1月底在加利福尼亚州蒙特雷举行,为期2天。9名美国和7名日本免疫学家介绍并讨论了他们的最新结果。本研究从淋巴细胞定向分化相关基因、T细胞对抗原的加工和识别、超抗原、细胞因子及其受体、免疫功能紊乱等方面,利用基因打靶技术制备了RAG-1和RAG-2缺陷小鼠。由于完全缺乏淋巴细胞,小鼠表现出严重的联合免疫缺陷,证实这些基因参与了IG和T细胞受体基因的重组。超抗原可以激活大量携带靶V β的T细胞,这可能导致疾病,如中毒性休克。EB病毒是一种超抗原,在类风湿性关节炎等自身免疫性疾病中可能参与T细胞的活化,并讨论了EB病毒细胞因子受体的独特结构。IL-6和IL-5受体均由两条多肽链组成,即配体结合链和信号转导子。信号转导子通常用于几种细胞因子受体系统,如:例如,IL-5、IL-3和GM-CSF利用相同的信号转换器,IL-6和LIF利用相同的gp 130作为信号转换器。这种独特的系统可能能够解释多效性和冗余的细胞因子。
英文摘要
The US-Japan Immunology Symposium was held for 2 days at the end of January at Monterey, CA. Nine US and seven Japanese immunologists presented and discussed their up-to-date results. The discussion was focused on the topics i) genes involved in the commitment of lymphoid cells, ii) antigen processing and recognition by T cells, iii) superantigens iv) cytokines and their receptors and v) immune disorders.The RAG-1 and RAG-2 deficient mice were prepared by gene targeting technology. The mice showed a severe combined immune deficiency due to the total lack of lymphoid cells confirming the involvement of these genes in the recombination of the Ig and T cell receptor genes.The class I MHC epitope of a bacterial pathogen which is a nonamer peptide, was identified. Superantigens can activate large number of T cells bearing the target V beta and this can lead to diseases, such as toxic shock. EB virus was shown to make a superantigen and suggested to be involved in the activation of T cells in autoimmune diseases such as rheumatoid arthritis.An unique structure of cytokine receptors was discussed. Both IL-6 and IL-5 receptors consist of two polypeptide chains, a ligand binding chain and a signal transducer. Signal transducers are common by utilized between several cytokine receptor systems, i. e., IL-5, IL-3 and GM-CSF utilize the same signal transducer and IL-6 and LIF utilize the same gpl30 as a signal transducer. This unique system may be able to explain pleiotropy and redundancy of cytokines.
期刊论文(15)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Murakami, M., M. Narazaki, M. Hibi, H. Yawata, K. Yasukawa, M. Hamaguchi, T Taga, and T. Kishimoto.: "Critical cytoplasmic region of the IL-6 signal tranducer, gp130, is conserved in the cytokine receptor family." Proc. Natl. Acad. Sci., USA. 88. 11349-11
Murakami, M., M. Narazaki, M. Hibi, H. Yawata, K. Yasukawa, M. Hamaguchi, T Taga, and T. Kishimoto.:“IL-6 信号转导子 gp130 的关键细胞质区域是保守的
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ogawa,M.,Y.Matsuzaki,S.Nishikawa,SI.Hayashi,SI.Nishikawa,et al.: "Expression and function of c-kit in hemopoietic progenitor cells." J.Exp.Med.174. 63-71 (1991)
Okawa,M.,Y.Matsuzaki,S.Nishikawa,SI.Hayashi,SI.Nishikawa,et al.:“c-kit 在造血祖细胞中的表达和功能。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 15 条
    Studies on molecular mechanisms of autoimmune diseases
    • 批准号:
      05044166
    • 项目类别:
      Grant-in-Aid for international Scientific Research
    • 资助金额:
      $1.92万
    • 财政年份:
      1993
    • 负责人:
      KISHIMOTO Tadamitsu
    • 依托单位:
    免疫病の分子・遺伝子治療に関する研究
    • 批准号:
      05102005
    • 项目类别:
      Grant-in-Aid for Specially Promoted Research
    • 资助金额:
      $153.6万
    • 财政年份:
      1993
    • 负责人:
      KISHIMOTO Tadamitsu
    • 依托单位:
    Studies on the regulation of gene expression in lymphoid cells.
    • 批准号:
      04044115
    • 项目类别:
      Grant-in-Aid for international Scientific Research
    • 资助金额:
      $2.3万
    • 财政年份:
      1992
    • 负责人:
      KISHIMOTO Tadamitsu
    • 依托单位:
    Studies on molecular regulation of the immune system
    • 批准号:
      01065005
    • 项目类别:
      Grant-in-Aid for Specially Promoted Research
    • 资助金额:
      $136.32万
    • 财政年份:
      1989
    • 负责人:
      KISHIMOTO Tadamitsu
    • 依托单位:
    国内基金
    海外基金
    补骨脂异黄酮通过靶向RAG1重塑骨髓免疫微环境改善老年骨质疏松症的作用及机制
    • 批准号:
      2026JJ81766
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      胡阴
    • 依托单位:
    铜转运蛋白CTR1通过FOXO1-RAG1/2通路调控B细胞发育与体液免疫应答的功能与机制研究
    • 批准号:
      --
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      30万元
    • 批准年份:
      2022
    • 负责人:
      蒋宇航
    • 依托单位:
    RAG1相分离聚集对V(D)J基因重组的必要性
    • 批准号:
      31970837
    • 项目类别:
      面上项目
    • 资助金额:
      59.0万元
    • 批准年份:
      2019
    • 负责人:
      张志新
    • 依托单位:
    雄黄有效成分硫化砷通过调控NFATc3-RAG1-DSB杀伤胃癌细胞的机制
    • 批准号:
      81874353
    • 项目类别:
      面上项目
    • 资助金额:
      57.0万元
    • 批准年份:
      2018
    • 负责人:
      陈思宇
    • 依托单位: